50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“Our mission is to deliver advanced therapies to improve the lives of patients and families battling autoimmune and inflammatory diseases.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-04-1565% match
“Our mission is to bring hope with life-changing therapies to patients and families that are affected by rare and niche allergic and immunological diseases.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2262% match
“Our mission is to deliver significant clinical benefit to patients suffering from disorders that are linked to dysfunctional signaling of the TGF-ß family of proteins.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0461% match
“Our mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1059% match
“Our mission is to bring off-the-shelf cellular immunotherapies with disease-transforming potential initially to patients with autoimmune diseases and cancer.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2659% match
“Our mission is to liberate patients from autoimmune diseases through the curative potential of cell therapy.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2659% match
“Our mission is to ensure families are supported during the most difficult time of their lives.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-09-2358% match
“Our mission is to serve the needs of families with young children, with a vision to be the world’s favorite brands in young children’s apparel and related products.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-02-2558% match
“Our mission is to serve middle-income families by helping them make informed financial decisions and providing them with a strategy and tools to gain financial independence.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-02-2858% match
“Our mission is to provide therapeutic relief to those suffering from debilitating rare diseases that have limited or no treatment options to help them live their best possible lives and achieve their full potential.”In use 2024 – now·1 sighting·SEC Form 20-F, filed 2024-04-3058% match
“Our mission is to develop therapeutics that restore healthy immune regulation for patients with severe autoimmune and inflammatory diseases.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1058% match
“Our mission is to develop innovative therapies to address areas of high unmet medical need, initially in RASopathies for NF1.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3057% match
“Our mission is to develop and commercialize therapies with the potential to transform the lives of patients and their families living with rare diseases.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-0157% match
“Our mission is to simplify access to complex therapies and improve health outcomes for patients with chronic, rare, or specialty conditions.”In use 2025 – now·1 sighting·SEC Form S-1, filed 2025-11-0756% match
“Our mission is to improve the lives of families and caregivers by helping them connect in a reliable and easy way.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-03-0756% match
“Our mission is to address a broad range of diseases where chronic inflammation and immune dysfunction are primary drivers of pathology.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3056% match
“Our mission is to acquire, organize and manage the resources required to offer personalized and professional financial services in a manner that demonstrates our concern for understanding and meeting the needs of the individuals, families, businesses and other organizations in our marketplace.”In use 2002 – now·1 sighting·SEC Form 10-K, filed 2002-03-2856% match
“Our mission is to help physicians improve the lives of people with chronic conditions through life-enhancing products and services.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-03-0456% match
“Our mission is to deliver innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-2456% match
“Our mission is to create life-changing T cell therapies for patients with cancer and autoimmune disorders.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0456% match
“Our mission is to create therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-04-1656% match
“Our mission is to improve health for all with great, innovative, affordable medicines so that people with life-changing or chronic conditions can gain access to the medicines they need, physicians can treat patients without barriers to prescribing, and health systems can afford to make those medicines available, without restrictions, to the populations they serve in a financially sustainable manner.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-2355% match
“Our mission is to improve patients’ daily lives and prevent the long-term effects of uncontrolled inflammation that are a consequence of the limitations of existing therapies.”In use 2026 – now·1 sighting·SEC Form S-1, filed 2026-04-1755% match
“Our mission is to bring to market therapies that address high unmet medical needs of patients with genetic mitochondrial diseases.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2755% match
“Our mission is to improve the lives of patients who suffer from rare diseases for which there are limited or no available treatments, with an initial therapeutic focus on Cirrhosis ascites, patients suffering from AIDS, Cancer and chronic pain, nausea and discomfort associated with chemotherapy and neuropathy.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-11-0655% match
“Our purpose is to issue the notes which represent our asset-backed obligations and to lend an amount equal to the proceeds of the notes to Funding.”In use 2003 – now·1 sighting·SEC Form 424B4, filed 2003-01-2455% match
“The product’s purpose is to help human beings suffering from pain.”In use 2015 – now·1 sighting·SEC Form S-1/A, filed 2015-07-2955% match
“Our mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function to enable patients with these disorders to live fuller and healthier lives.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-04-2355% match
“Our mission is to provide effective prevention and treatment solutions to alleviate patients’ sufferings from illnesses.”In use 2025 – now·1 sighting·SEC Form 424B4, filed 2025-10-0955% match
“Our mission is to bring life-changing therapeutics to people living with rare diseases.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-1255% match
“Our mission is to discover and develop effective biologic treatments applicable to a range of challenging, validated targets with high potential to help people with life-threatening conditions.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1955% match
“Our mission is to improve patient outcomes in the areas of neurodegenerative and oncological diseases by developing safe and effective cellular therapies that leverage the power of a patient’s immune system.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-10-0855% match
“Our mission is to expand our portfolio into a wide range of muscle diseases and become a leader in this area by advancing life-transforming therapeutics for patients with serious muscle diseases.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-03-0455% match
“Company’s mission is to identify subgroups of people with high costs and disability and create and implement programs and interventions that improve their health, resulting in dramatic reductions in the cost of their care.”In use 2009 – now·1 sighting·SEC Form 10-K/A, filed 2009-07-2055% match
“Our mission is to improve the lives of patients with CF by providing novel and cost-effective treatment options.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-03-1055% match
“Our mission is to develop verekitug to be the first approved antagonist of the TSLP receptor to benefit patients suffering from severe inflammatory diseases that are underserved by today’s standard of care.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2655% match
“Our purpose is to issue the notes which represent our mortgage- backed obligations and to lend an amount equal to the proceeds of the notes to Funding.”In use 2004 – now·1 sighting·SEC Form 424B4, filed 2004-05-2055% match
“Our mission is to develop life-changing genetic medicines for people and their families impacted by devastating neurological diseases.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2455% match
“Our mission is to provide our clients with high-quality, full-service support for their clinical trials.”In use 2011 – now·1 sighting·SEC Form 10-K, filed 2011-10-0355% match
“Our mission is to discover, develop and deliver life-changing treatments for people living with grievous blood-based disorders, starting with SCD.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-02-2455% match
“Our mission is to develop life-changing therapies for patients suffering from debilitating liver diseases.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-03-0955% match
“Our mission is to team with clinicians to advance innovative device therapies that modulate the ANS to meaningfully improve the lives of people with chronic disease.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1355% match
“Our mission is to be a profitable community-oriented provider of banking products and services to individuals and small businesses, including residential and commercial mortgages, consumer loans, commercial loans, and a variety of deposit instruments.”In use 2001 – now·1 sighting·SEC Form S-1/A, filed 2001-08-1054% match
“Our mission is to help physicians improve the lives of patients suffering from aortic disease through excellence in research, product development, manufacturing, sales and service.”In use 2015 – now·1 sighting·SEC Form 10-K, filed 2015-03-0954% match
“Our mission is to become a global leader in the treatment of rare diseases through commercializing, developing and acquiring novel rare disease products.”In use 2021 – now·1 sighting·SEC Form 424B4, filed 2021-01-1454% match
“Our mission is to address the significant need for new treatments in cancers of the bone in children and young adults.”In use 2025 – now·1 sighting·SEC Form S-1, filed 2025-08-0454% match
“Our mission is to partner with our members in Illinois and Wisconsin to provide them competitively priced funding, a reasonable return on their investment in the Bank, and support for their community investment activities.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1054% match
“Our mission is to be a reliable provider of funding, liquidity, and services to promote housing, jobs and general prosperity through products and services that assist our members in supporting their communities.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1254% match
“Our mission is to identify, develop, and, directly or through collaborations, bring to market novel products for the treatment of rare and ultra-rare diseases or conditions.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-03-1454% match
“Our mission is to develop first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy, or DMD, and other rare disorders.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-03-2754% match
Showing 1–50 of 50